How Long Do Benzodiazepines Stay in Your System? Complete Detection Guide

Written by Jonathan Strum

& Medically Reviewed by Leila Khurshid BCPS, PharmD

Medically Reviewed

Up to Date

This article was reviewed by a medical professional to guarantee the delivery of accurate and up-to- date information. View our research policy.

Last Updated - 6/17/2022

View our editorial policy
If you or a loved one is struggling with addiction, help is available. Speak with a Recovery Advocate by calling (855) 602-7202 now.

Quick Reference for Immediate Needs

If you have an upcoming drug test or medical procedure, here are the essential timeframes:

Urine Testing (most common):

  • Short-acting benzos (Xanax, Ativan): 1-4 days
  • Long-acting benzos (Valium, Klonopin): 3-30 days
  • Chronic users: Up to 6 weeks or longer

Blood Testing:

  • Most benzodiazepines: 12-24 hours
  • Long-acting types: Up to 48 hours

Saliva Testing:

  • Generally: 1-3 days
  • Varies significantly by specific medication

Hair Testing:

  • All benzodiazepines: Up to 90 days
  • Detection begins 7-10 days after use

Critical factors affecting your timeline: dosage, frequency of use, which specific benzodiazepine, your metabolism, age, weight, and overall health.

Understanding Benzodiazepine Elimination

Benzodiazepines represent a class of medications with widely varying elimination patterns. Unlike many drugs that follow predictable timelines, benzodiazepine detection depends on complex interactions between the specific medication’s chemical properties, your individual physiology, and your pattern of use.

Why benzodiazepines are different:

  • Each medication has unique elimination characteristics
  • Active metabolites can extend detection far beyond the parent drug
  • Accumulation in fatty tissue affects long-term users differently
  • Individual genetic variations significantly impact processing speed

The complexity of “how long” questions: When someone asks how long benzodiazepines stay in their system, they’re actually asking several different questions simultaneously: How long will I feel effects? When will drug tests be negative? When is it safe to drive or operate machinery? When can I take other medications safely? Each has a different answer.

Benzodiazepine Classification and Half-Lives

Short-Acting Benzodiazepines

Alprazolam (Xanax)

  • Half-life: 6-12 hours
  • Urine detection: 1-4 days
  • Active metabolites: Alpha-hydroxyalprazolam (6-12 hours)
  • Special considerations: Immediate-release vs. extended-release formulations

Lorazepam (Ativan)

  • Half-life: 10-20 hours
  • Urine detection: 1-6 days
  • Active metabolites: Minimal (advantage for elderly patients)
  • Special considerations: Direct conjugation, less affected by liver disease

Triazolam (Halcion)

  • Half-life: 1.5-5 hours
  • Urine detection: 1-2 days
  • Active metabolites: Alpha-hydroxytriazolam (short-lived)
  • Special considerations: Shortest detection window of common benzos

Oxazepam (Serax)

  • Half-life: 4-15 hours
  • Urine detection: 1-3 days
  • Active metabolites: None
  • Special considerations: Safest for liver impairment

Intermediate-Acting Benzodiazepines

Clonazepam (Klonopin)

  • Half-life: 18-50 hours
  • Urine detection: 3-14 days
  • Active metabolites: 7-aminoclonazepam (22-54 hours)
  • Special considerations: Long half-life despite intermediate classification

Temazepam (Restoril)

  • Half-life: 3-18 hours
  • Urine detection: 1-6 days
  • Active metabolites: Minimal
  • Special considerations: Primarily used for sleep, varies widely between individuals

Estazolam (ProSom)

  • Half-life: 10-24 hours
  • Urine detection: 2-8 days
  • Active metabolites: 4-hydroxyestazolam
  • Special considerations: Less commonly prescribed, limited data

Long-Acting Benzodiazepines

Diazepam (Valium)

  • Half-life: 20-100 hours (highly variable)
  • Urine detection: 3-30 days
  • Active metabolites: Desmethyldiazepam (36-200 hours), Temazepam, Oxazepam
  • Special considerations: Longest detection window due to active metabolites

Chlordiazepoxide (Librium)

  • Half-life: 5-30 hours
  • Urine detection: 3-28 days
  • Active metabolites: Desmethylchlordiazepoxide (18 hours), Demoxepam (14-95 hours)
  • Special considerations: Often used for alcohol withdrawal

Flurazepam (Dalmane)

  • Half-life: 2-3 hours (parent drug)
  • Urine detection: 7-30 days
  • Active metabolites: Desalkylflurazepam (47-100 hours)
  • Special considerations: Parent drug short-lived, but metabolite very long

Clorazepate (Tranxene)

  • Half-life: 30-200 hours
  • Urine detection: 7-28 days
  • Active metabolites: Converted to desmethyldiazepam
  • Special considerations: Prodrug, same active metabolite as Valium

Factors Affecting Detection Time

Individual Physiological Factors

Age-Related Changes Metabolism slows significantly with age, particularly affecting liver enzyme function. A 70-year-old may eliminate benzodiazepines 50-75% slower than a 25-year-old.

Age-specific considerations:

  • Children: Faster metabolism, shorter detection times
  • Adults 18-65: Standard elimination rates apply
  • Elderly (65+): Significantly extended detection times
  • Very elderly (80+): May have detection times 2-3 times longer

Body Weight and Composition Benzodiazepines are lipophilic (fat-soluble), meaning they store in fatty tissue and release slowly over time.

Weight impact on detection:

  • Higher body fat percentage: Longer detection times
  • Lower body fat: Faster elimination
  • Muscle mass: Generally faster metabolism
  • Obesity: Can extend detection significantly

Gender Differences Women typically have higher body fat percentages and different enzyme activity levels, often resulting in longer detection times.

Gender-specific factors:

  • Women: Generally 10-30% longer detection times
  • Hormonal fluctuations affect metabolism
  • Pregnancy: Dramatically altered elimination (medical supervision required)
  • Menstrual cycle: May affect elimination rates

Liver Function and Metabolism

Hepatic Enzyme Systems Most benzodiazepines are metabolized by liver enzymes, particularly the CYP3A4 system. Any condition or medication affecting these enzymes changes elimination times.

Liver health impact:

  • Normal liver function: Standard elimination times
  • Mild liver impairment: 25-50% longer detection
  • Moderate impairment: 50-100% longer detection
  • Severe liver disease: Detection times may extend 2-5 times normal

Medications affecting liver enzymes:

  • CYP3A4 inhibitors (certain antibiotics, antifungals): Slower elimination
  • CYP3A4 inducers (some seizure medications): Faster elimination
  • Alcohol: Competes for same enzymes, slows elimination

Kidney Function

While the liver metabolizes benzodiazepines, the kidneys eliminate the metabolites. Kidney function directly affects how quickly drug metabolites clear from your system.

Kidney function categories:

  • Normal function: Standard detection times
  • Mild impairment: Slightly extended detection
  • Moderate impairment: Significantly longer detection
  • Severe impairment: Dramatically extended detection times

Age-related kidney changes:

  • Kidney function declines approximately 1% per year after age 40
  • Many elderly patients have undiagnosed kidney impairment
  • Dehydration can temporarily worsen kidney function

Usage Patterns and Accumulation

Single Dose vs. Regular Use Single doses follow predictable elimination patterns, but regular use creates accumulation that dramatically extends detection times.

Accumulation patterns:

  • Daily use for 1 week: Minimal accumulation
  • Daily use for 1 month: Significant accumulation
  • Daily use for 6+ months: Extensive accumulation
  • Years of use: May take weeks to months for complete elimination

Dose-Dependent Elimination Higher doses saturate enzyme systems, leading to non-linear elimination where doubling the dose may triple the detection time.

Dosage impact examples:

  • Low therapeutic doses: Standard detection times
  • High therapeutic doses: 50-100% longer detection
  • Supratherapeutic doses: Unpredictably long detection

Drug Testing Methods and Detection Windows

Urine Testing (Most Common Method)

Urine testing accounts for approximately 85% of drug screening because it’s non-invasive, cost-effective, and provides reliable detection windows.

Standard urine test characteristics:

  • Immunoassay screening (initial test)
  • GC-MS confirmation (if positive)
  • Detection threshold: 200-300 ng/mL
  • False positive rate: Less than 5%

Factors affecting urine detection:

  • Urine concentration and pH
  • Hydration status
  • Time of day (first morning urine most concentrated)
  • Kidney function
  • Concurrent medications

Specific urine detection windows:

Short-acting benzodiazepines:

  • Single use: 1-3 days
  • Weekly use: 2-5 days
  • Daily use (1 month): 3-7 days
  • Long-term daily use: 1-4 weeks

Long-acting benzodiazepines:

  • Single use: 3-7 days
  • Weekly use: 1-2 weeks
  • Daily use (1 month): 2-4 weeks
  • Long-term daily use: 4-6 weeks or longer

Blood Testing (Rare but Precise)

Blood testing provides the most accurate picture of current impairment but has a very short detection window.

Blood test applications:

  • Accident investigations
  • Medical emergencies
  • Legal proceedings requiring impairment evidence
  • Research studies

Blood detection characteristics:

  • Parent drug: 6-24 hours
  • Active metabolites: Up to 48 hours
  • Peak concentrations: 1-4 hours after oral dose
  • Correlation with impairment: Good for recent use

Factors affecting blood detection:

  • Time since last dose
  • Route of administration
  • Concurrent medications
  • Individual metabolism rate

Saliva Testing (Increasing Use)

Saliva testing is becoming more popular because it’s difficult to adulterate and reflects recent use patterns.

Saliva test advantages:

  • Non-invasive collection
  • Difficult to tamper with
  • Reflects unbound (active) drug concentrations
  • Good correlation with blood levels

Saliva detection windows:

  • Most benzodiazepines: 1-3 days
  • Varies significantly by specific medication
  • Affected by mouth pH and saliva production
  • May miss chronic low-level use

Factors affecting saliva detection:

  • Oral health and hygiene
  • Saliva production rate
  • Recent food or drink consumption
  • Mouth pH levels

Hair Follicle Testing (Longest Detection)

Hair testing provides the longest detection window but cannot detect very recent use.

Hair test characteristics:

  • Detection window: Up to 90 days
  • Hair growth rate: 0.5 inches per month
  • Sample length: 1.5 inches typically tested
  • Detection delay: 7-10 days after use

Hair test limitations:

  • Cannot detect use within past week
  • Affected by hair treatments and color
  • May vary by hair type and ethnicity
  • More expensive than other methods

Environmental contamination:

  • Passive exposure rarely causes positive results
  • Washing procedures remove external contamination
  • Internal drug incorporation required for positive test

Special Circumstances and Considerations

Prescription vs. Non-Prescription Use

Legal prescription holders: Having a valid prescription provides legal protection but doesn’t change detection times. Important considerations include:

Medical disclosure:

  • Inform testing facility about prescriptions
  • Provide prescription bottle or physician letter
  • Medical Review Officer (MRO) evaluation
  • “Negative” result reported to employer if prescription verified

Workplace policies:

  • Safety-sensitive positions may have stricter policies
  • Some employers require fitness-for-duty evaluations
  • Department of Transportation (DOT) testing has specific rules
  • Professional licenses may have additional requirements

Counterfeit and Street Benzodiazepines

Risks of non-pharmaceutical benzodiazepines:

  • Unknown potency and purity
  • Dangerous adulterants
  • Unpredictable elimination times
  • May contain substances not detected by standard tests

Common adulterants:

  • Fentanyl (extremely dangerous)
  • Other benzodiazepines not prescribed
  • Inactive fillers affecting absorption
  • Stimulants or other active drugs

Drug Interactions Affecting Elimination

Medications that slow benzodiazepine elimination:

  • Ketoconazole and other antifungals
  • Erythromycin and clarithromycin
  • Cimetidine (Tagamet)
  • Grapefruit juice
  • Fluoxetine (Prozac)

Medications that speed elimination:

  • Carbamazepine (Tegretol)
  • Phenytoin (Dilantin)
  • Rifampin
  • St. John’s Wort
  • Chronic alcohol use (enzyme induction)

Alcohol interactions:

  • Acute alcohol use: Slows elimination
  • Chronic alcohol use: May speed elimination through enzyme induction
  • Alcohol withdrawal: Unpredictable effects on metabolism

Medical and Safety Considerations

When Detection Time Matters Medically

Pre-surgical considerations: Benzodiazepines can interact with anesthesia and affect post-operative recovery. Inform anesthesiologists about recent use.

Emergency medical situations: Accurate medication history helps emergency physicians make safer treatment decisions, especially regarding:

  • Additional sedating medications
  • Reversal agents (flumazenil)
  • Drug interaction potential
  • Withdrawal risk assessment

Other medical procedures:

  • Certain diagnostic procedures
  • Medication trials for mental health
  • Pain management protocols
  • Addiction treatment planning

Withdrawal Risk Assessment

Factors increasing withdrawal severity:

  • Duration of regular use
  • Dosage levels
  • Type of benzodiazepine
  • Individual susceptibility
  • Concurrent medical conditions

Timeline for withdrawal risk:

  • Regular use 2-4 weeks: Mild withdrawal possible
  • Regular use 1-3 months: Moderate withdrawal likely
  • Regular use 6+ months: Severe withdrawal risk
  • Years of use: Potentially dangerous withdrawal

Medical supervision requirements:

  • Gradual tapering schedules
  • Monitoring for seizures
  • Management of anxiety and insomnia
  • Emergency intervention capabilities

Driving and Operating Machinery

Impairment vs. detection: Drug detection doesn’t necessarily indicate impairment, but benzodiazepines can cause impairment that lasts beyond therapeutic effects.

Residual effects:

  • Next-day drowsiness
  • Reduced reaction times
  • Impaired coordination
  • Memory problems
  • Poor judgment

Legal considerations:

  • DUI charges possible even with valid prescription
  • “Zero tolerance” policies in some jurisdictions
  • Enhanced penalties for prescription drug impairment
  • Professional licensing implications

Strategies for Faster Elimination

Evidence-Based Approaches

Hydration optimization: Adequate hydration supports kidney function and may modestly speed elimination. However, excessive water consumption before testing can dilute samples and require retesting.

Optimal hydration guidelines:

  • 8-10 glasses of water daily
  • Monitor urine color (pale yellow optimal)
  • Avoid excessive consumption before testing
  • Include electrolyte replacement if sweating heavily

Liver support: Supporting healthy liver function may help with benzodiazepine metabolism:

  • Avoid alcohol and liver-toxic substances
  • Maintain healthy diet with adequate protein
  • Consider milk thistle (consult physician first)
  • Get adequate sleep for liver recovery

Physical activity: Moderate exercise may support overall metabolism and circulation:

  • Regular aerobic exercise
  • Avoid excessive exercise which can stress systems
  • Include both cardio and strength training
  • Listen to your body and don’t overdo it

What Doesn’t Work

Myths about speeding elimination:

  • “Detox” drinks and supplements have no proven effect
  • Activated charcoal doesn’t remove drugs already absorbed
  • Excessive exercise may actually slow elimination by stressing the body
  • Dietary manipulation has minimal impact
  • Sauna use doesn’t significantly speed drug elimination

Potentially dangerous approaches:

  • Extreme dehydration or overhydration
  • Excessive exercise during withdrawal
  • Unproven supplements or herbs
  • Drastic dietary changes
  • Self-medication with other substances

Workplace and Legal Considerations

Employment Drug Testing Policies

Pre-employment screening:

  • Usually includes benzodiazepines in extended panels
  • Disclosure of prescriptions typically protects employment
  • Safety-sensitive positions may have stricter requirements
  • Background check may include prescription drug monitoring

Random workplace testing:

  • Varies by industry and company policy
  • Transportation industry has federal requirements
  • Healthcare workers often subject to testing
  • Manufacturing and construction commonly test

Post-accident testing:

  • Required in many industries after workplace accidents
  • May affect workers’ compensation claims
  • Can influence legal liability determinations
  • Results may be used in civil or criminal proceedings

Legal System Implications

Criminal justice testing:

  • Probation and parole often include drug testing
  • Court-ordered testing for various legal proceedings
  • Child custody cases may require drug screening
  • Drug courts have specific testing requirements

Professional licensing:

  • Healthcare professionals subject to testing
  • Legal professionals may face testing
  • Commercial drivers have federal testing requirements
  • Pilots and air traffic controllers have strict policies

Legal protections and limitations:

  • Americans with Disabilities Act considerations
  • State laws vary on prescription drug discrimination
  • Good Samaritan laws for overdose situations
  • Confidentiality requirements for medical information

Getting Help for Benzodiazepine Dependence

Recognizing Problem Use

Warning signs of dependence:

  • Taking more than prescribed
  • Using other people’s medications
  • Doctor shopping for multiple prescriptions
  • Inability to function without medication
  • Withdrawal symptoms when stopping

Physical signs:

  • Tolerance requiring dose increases
  • Withdrawal symptoms between doses
  • Sleep problems despite medication
  • Memory and concentration difficulties
  • Coordination problems

Behavioral changes:

  • Preoccupation with medication supply
  • Social isolation or relationship problems
  • Work or school performance decline
  • Legal or financial problems related to use
  • Continued use despite negative consequences

Treatment Options

Medical detoxification:

  • Gradual tapering under medical supervision
  • Medications to prevent seizures and manage symptoms
  • 24/7 monitoring during dangerous withdrawal periods
  • Treatment of complications as they arise

Outpatient treatment:

  • Regular medical monitoring
  • Counseling and therapy services
  • Support groups and peer counseling
  • Flexibility for work and family obligations

Inpatient treatment:

  • Intensive medical supervision
  • Comprehensive addiction treatment
  • Treatment of co-occurring mental health conditions
  • Structured environment for early recovery

Medication-assisted treatment:

  • Anticonvulsants to prevent seizures
  • Sleep medications with different mechanisms
  • Anxiety medications that don’t cause dependence
  • Treatment of underlying mental health conditions

Support Resources

Professional organizations:

  • American Society of Addiction Medicine
  • Substance Abuse and Mental Health Services Administration
  • National Association of Addiction Treatment Providers
  • Local addiction treatment centers

Support groups:

  • Benzodiazepine support groups (online and in-person)
  • Narcotics Anonymous
  • SMART Recovery
  • Refuge Recovery

Online resources:

  • Benzodiazepine withdrawal support forums
  • Educational websites about benzodiazepine dependence
  • Tapering guides and schedules
  • Harm reduction information

Frequently Asked Questions

Can I speed up elimination by drinking lots of water? Adequate hydration supports normal kidney function, but excessive water consumption doesn’t significantly speed benzodiazepine elimination. Drinking too much water before drug testing can dilute samples and require retesting.

How accurate are at-home drug tests for benzodiazepines? At-home tests are generally reliable for detecting benzodiazepines, with accuracy rates above 95%. However, they may not detect all benzodiazepine types and cannot distinguish between different medications in the class.

Will one dose show up on a drug test after a week? For most benzodiazepines, a single dose would not be detectable in urine after one week. However, long-acting benzodiazepines like Valium might still be detectable, especially in people with slower metabolism.

Do different brands of the same medication have different detection times? Generic vs. brand-name versions of the same benzodiazepine should have similar detection times. However, immediate-release vs. extended-release formulations may have different elimination patterns.

Can prescription drug monitoring programs see my benzodiazepine use? Yes, prescription drug monitoring programs track controlled substance prescriptions, including benzodiazepines. Healthcare providers and pharmacists can access this information to monitor for potential misuse or dangerous combinations.

What happens if I test positive but have a valid prescription? Valid prescriptions typically protect against employment consequences. The test result goes to a Medical Review Officer (MRO) who verifies the prescription and reports a “negative” result to the employer if the prescription is legitimate and current.

Conclusion

Understanding how long benzodiazepines stay in your system involves complex interactions between medication type, individual physiology, usage patterns, and testing methods. While general guidelines provide helpful estimates, individual experiences can vary significantly based on numerous factors.

Key takeaways for practical decision-making:

  • Specific benzodiazepine type matters more than general “benzo” category
  • Regular use dramatically extends detection times beyond single-dose estimates
  • Individual factors like age, weight, and health significantly affect elimination
  • Professional medical guidance is essential for safe discontinuation
  • Legal protections exist for legitimate prescription use

For individuals taking benzodiazepines as prescribed: Maintain open communication with healthcare providers about any concerns regarding detection times, side effects, or dependence risks. Follow prescribed dosing schedules and never abruptly discontinue without medical supervision.

For those concerned about drug testing: Honest disclosure of valid prescriptions provides legal protection in most situations. Understanding your rights and the testing process helps reduce anxiety about legitimate medication use.

For anyone experiencing problems with benzodiazepine use: Professional help is available and effective. Early intervention improves outcomes and reduces the risk of serious complications from dependence or withdrawal.

The goal is not just understanding detection times, but using this information to make informed decisions about health, safety, and treatment. Whether managing anxiety with prescribed medication or addressing problematic use, professional medical guidance ensures the safest and most effective approach to benzodiazepine use and discontinuation.

Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Detection times are estimates and can vary significantly between individuals. Anyone taking benzodiazepines should consult with qualified healthcare providers regarding use, discontinuation, or testing concerns. Benzodiazepine withdrawal can be dangerous and requires medical supervision.

Sources:

Addiction Medicine – Clinical Management of Benzodiazepine Dependence and Withdrawal

Clinical Pharmacokinetics – Benzodiazepine Metabolism and Elimination

Journal of Analytical Toxicology – Detection Windows for Benzodiazepines in Various Matrices

Therapeutic Drug Monitoring – Individual Factors Affecting Benzodiazepine Pharmacokinetics

Sources

Drug Enforcement Agency. “Benzodiazepines – Drug Fact Sheet.” April 2020. Accessed February 15, 2022. Alcohol and Drug Foundation. “Benzodiazepines.” November 10, 2021. Accessed February 15, 2022. PsychDB. “Introduction to Benzodiazepines.” January 25, 2022. Accessed February 15, 2022. The Ashton Manual. “Benzodiazepine Equivalence Table.” April 2007. Accessed February 15, 2022. Redwood Toxicology Laboratory. “Benzodiazepines Drug Information.” 2021. Accessed February 15, 2022. Cone, Edward. “Interpretation of Oral Fluid Tests for Drugs of Abuse.” Annals of the New York Academy of Sciences, 2007. Accessed February 15, 2022. ARUP Laboratories. “DRUG PLASMA HALF-LIFE AND URINE DETECTION WINDOW.” October 2021. Accessed March 6, 2022. Sramek, J. “Detection of benzodiazepines in human hair by radioimmunoassay.” Annals of Pharmacotherapy, April 1992. Accessed February 15, 2022. Singh, G. “Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System.” American Journal of Therapeutics, March 2000. Accessed February 15, 2022. Centers for Disease Control. “Antidepressant Use Among Adults: United States, 2015-2018.” September 2020. Accessed February 15, 2022. ARUP Laboratories. “Benzodiazepines.” February 2012. Accessed February 15, 2022. Rollins, DE, Jennison, TA, and Jones, G. “Investigation of interference by nonsteroidal anti-inflammatory drugs in urine tests for abused drugs.” April 1990. Accessed March 8, 2022.

View Sources

Drug Enforcement Agency. “Benzodiazepines – Drug Fact Sheet.” April 2020. Accessed February 15, 2022. Alcohol and Drug Foundation. “Benzodiazepines.” November 10, 2021. Accessed February 15, 2022. PsychDB. “Introduction to Benzodiazepines.” January 25, 2022. Accessed February 15, 2022. The Ashton Manual. “Benzodiazepine Equivalence Table.” April 2007. Accessed February 15, 2022. Redwood Toxicology Laboratory. “Benzodiazepines Drug Information.” 2021. Accessed February 15, 2022. Cone, Edward. “Interpretation of Oral Fluid Tests for Drugs of Abuse.” Annals of the New York Academy of Sciences, 2007. Accessed February 15, 2022. ARUP Laboratories. “DRUG PLASMA HALF-LIFE AND URINE DETECTION WINDOW.” October 2021. Accessed March 6, 2022. Sramek, J. “Detection of benzodiazepines in human hair by radioimmunoassay.” Annals of Pharmacotherapy, April 1992. Accessed February 15, 2022. Singh, G. “Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System.” American Journal of Therapeutics, March 2000. Accessed February 15, 2022. Centers for Disease Control. “Antidepressant Use Among Adults: United States, 2015-2018.” September 2020. Accessed February 15, 2022. ARUP Laboratories. “Benzodiazepines.” February 2012. Accessed February 15, 2022. Rollins, DE, Jennison, TA, and Jones, G. “Investigation of interference by nonsteroidal anti-inflammatory drugs in urine tests for abused drugs.” April 1990. Accessed March 8, 2022.

Authorship